Optimas Capital LTD Bio N Tech Se Transaction History

Optimas Capital LTD

  • $105 Million
  • Q3 2024

A detailed history of Optimas Capital LTD transactions in Bio N Tech Se stock. As of the latest transaction made, Optimas Capital LTD holds 8,400 shares of BNTX stock, worth $986,076. This represents 0.95% of its overall portfolio holdings.

Number of Shares
8,400
Holding current value
$986,076
% of portfolio
0.95%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$78.36 - $124.66 $658,224 - $1.05 Million
8,400 New
8,400 $997,000
Q2 2022

Aug 12, 2022
SELL
$123.25 - $186.24 $739,500 - $1.12 Million
-6,000 Closed
0 $0
Q1 2022

May 17, 2022
BUY
$126.25 - $231.85 $757,500 - $1.39 Million
6,000 New
6,000 $1.02 Million

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.5B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Optimas Capital LTD Portfolio

Follow Optimas Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Optimas Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Optimas Capital LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email